Skip to main content

Table 4 Clinical characteristics and outcomes in intervention group and control group patients after 6 months

From: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

 

Intervention group

Control group

T-value

Sig.

Mean (S.D.)

Mean (S.D.)

General overuse

11.93 (2.15)

12.63 (2.61)

2.197

0.029a

General harm

10.08 (2.25)

10.67 (2.90)

1.687

0.093

Beneficial effect of pharmaceuticals

15.35 (2.04)

15.25 (2.15)

0.356

0.722

Beliefs about medicines

35.36 (3.62)

38.12 (4.43)

5.055

<0.0001a

Sensitive

15.10 (2.56)

15.39 (3.10)

0.769

0.442

Necessity beliefs

19.00 (3.83)

18.50 (4.19)

0.939

0.349

Concern beliefs

12.05 (3.08)

13.14 (3.97)

2.278

0.024

Treatment Satisfaction Questionnaire for Medication (TSQM)

88.71 (10.77)

82.89 (13.40)

3.551

<0.0001a

Estimated weights for EQ-5D

0.68 (0.40)

0.66 (0.38)

0.356

0.722

Montgomery–Åsberg Depression Scale

20.65 (11.97)

20.86 (12.54)

0.129

0.897

Medication Adherence Scale

5.99 (1.88)

4.94 (1.94)

4.059

<0.0001a

  1. aSignificantly different